GLIMEPIRIDE 2 MG + METFORMIN HYDROCHLORIDE 1000 MG PR Tablets – GLIMRIL M2 DUO

GLIMEPIRIDE 2 MG + METFORMIN HYDROCHLORIDE 1000 MG PR Tablets – A well-rounded approach to manage T2DM with complementary actions.

GLIMRIL M2 DUO – GLIMEPIRIDE 2 MG + METFORMIN HYDROCHLORIDE 1000 MG PR Tablets combines Glimepiride, a sulfonylurea antidiabetic medication, with Metformin, a biguanide, to provide a synergistic approach to managing type 2 diabetes mellitus. Glimepiride acts by stimulating the pancreas to release insulin, thereby lowering blood glucose levels, while Metformin decreases glucose production by the liver and enhances insulin sensitivity in peripheral tissues. The PR (prolonged-release) formulation of Metformin allows for a gradual release of the drug into the bloodstream, leading to improved glycaemic control with a lower incidence of gastrointestinal side effects compared to immediate-release formulations.

Recommended by specialists:
✅Diabetologist: For Long-term diabetes and Insulin resistance T2DM management
✅General Physician: For Postprandial and fasting glucose level control

Key benefit of GLIMEPIRIDE 2 MG + METFORMIN HYDROCHLORIDE 1000 MG PR Tablets – GLIMRIL M2 DUO:
✅Synergistic Action: The combination of Glimepiride and Metformin targets diabetes management from two complementary mechanisms, leading to more effective control of blood glucose levels.
✅Prolonged Release: The PR formulation of Metformin allows for sustained release, promoting stable blood sugar levels throughout the day while minimizing the gastrointestinal side effects often associated with immediate-release Metformin.
✅Lower Risk of Hypoglycemia: When used at appropriate doses, Glimepiride has a lower risk of causing hypoglycemia compared to other sulfonylureas, particularly in combination with Metformin.

Indications –
✅ Long-term diabetes management
✅Postprandial and fasting glucose levels
✅Type 2 diabetes mellitus
✅Insulin resistance T2DM